Last update 21 Nov 2024

Autologous Rak Cells(Cancer Hospital Chinese Academy of Medical Sciences)

Overview

Basic Info

Drug Type
Cell therapy
Synonyms-
Target-
Mechanism-
Therapeutic Areas
NeoplasmsDigestive System DisordersUrogenital Diseases
Active Indication
Hepatocellular CarcinomaMetastatic Renal Cell CarcinomaKidney Neoplasms
Inactive Indication-
Originator Organization
PwC Biomedical Technology Co., Ltd.Cancer Hospital Chinese Academy of Medical SciencesCancer Hospital Chinese Academy of Medical Sciences
Active Organization
TaKaRa Biomedical Technology(Beijing) Co., Ltd.TaKaRa Biomedical Technology(Beijing) Co., Ltd.Cancer Hospital Chinese Academy of Medical SciencesCancer Hospital Chinese Academy of Medical SciencesPwC Biomedical Technology Co., Ltd.
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

3
Clinical Trials associated with Autologous Rak Cells(Cancer Hospital Chinese Academy of Medical Sciences)
CTR20231914 / RecruitingPhase 2
一项多中心、开放标签、随机对照的探索性Ⅱ期临床研究，评估自体RAK细胞在肝细胞癌外科根治性切除术后预防高危复发风险的有效性和安全性
[Translation] A multicenter, open-label, randomized, controlled, exploratory phase II clinical study to evaluate the efficacy and safety of autologous RAK cells in preventing high-risk recurrence after radical surgical resection of hepatocellular carcinoma
CTR20171124 / RecruitingPhase 1
评估自体RAK细胞在无法手术切除且≥1线全身治疗失败的转移性肾癌患者中安全性和初步临床疗效的Ⅰ期临床试验
[Translation] A phase I clinical trial to evaluate the safety and preliminary clinical efficacy of autologous RAK cells in patients with metastatic renal cancer who cannot be surgically resected and have failed ≥1 line of systemic therapy
ChiCTR1900021334 / CompletedPhase 1IIT
Evaluation of autologous RAK cell in surgical resection and =1 line or systemic treatment failure in patients with metastatic kidney cancer preliminary clinical efficacy and safety of I phase of clinical trials
100 Clinical Results associated with Autologous Rak Cells(Cancer Hospital Chinese Academy of Medical Sciences)
Login to view more data
100 Translational Medicine associated with Autologous Rak Cells(Cancer Hospital Chinese Academy of Medical Sciences)
Login to view more data
100 Patents (Medical) associated with Autologous Rak Cells(Cancer Hospital Chinese Academy of Medical Sciences)
Login to view more data
100 Deals associated with Autologous Rak Cells(Cancer Hospital Chinese Academy of Medical Sciences)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hepatocellular CarcinomaPhase 2
CN
PwC Biomedical Technology Co., Ltd.
10 Oct 2023
Metastatic Renal Cell CarcinomaPhase 1
CN
TaKaRa Biomedical Technology(Beijing) Co., Ltd.TaKaRa Biomedical Technology(Beijing) Co., Ltd.
26 Sep 2017
Metastatic Renal Cell CarcinomaPhase 1
CN
Cancer Hospital Chinese Academy of Medical SciencesCancer Hospital Chinese Academy of Medical Sciences
26 Sep 2017
Kidney NeoplasmsIND Approval
CN
PwC Biomedical Technology Co., Ltd.
29 Nov 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free